Literature DB >> 27733284

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

.   

Abstract

BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 provides an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden of disease. By providing national and subnational assessments spanning the past 25 years, this study can inform debates on the importance of addressing risks in context.
METHODS: We used the comparative risk assessment framework developed for previous iterations of the Global Burden of Disease Study to estimate attributable deaths, disability-adjusted life-years (DALYs), and trends in exposure by age group, sex, year, and geography for 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks from 1990 to 2015. This study included 388 risk-outcome pairs that met World Cancer Research Fund-defined criteria for convincing or probable evidence. We extracted relative risk and exposure estimates from randomised controlled trials, cohorts, pooled cohorts, household surveys, census data, satellite data, and other sources. We used statistical models to pool data, adjust for bias, and incorporate covariates. We developed a metric that allows comparisons of exposure across risk factors-the summary exposure value. Using the counterfactual scenario of theoretical minimum risk level, we estimated the portion of deaths and DALYs that could be attributed to a given risk. We decomposed trends in attributable burden into contributions from population growth, population age structure, risk exposure, and risk-deleted cause-specific DALY rates. We characterised risk exposure in relation to a Socio-demographic Index (SDI).
FINDINGS: Between 1990 and 2015, global exposure to unsafe sanitation, household air pollution, childhood underweight, childhood stunting, and smoking each decreased by more than 25%. Global exposure for several occupational risks, high body-mass index (BMI), and drug use increased by more than 25% over the same period. All risks jointly evaluated in 2015 accounted for 57·8% (95% CI 56·6-58·8) of global deaths and 41·2% (39·8-42·8) of DALYs. In 2015, the ten largest contributors to global DALYs among Level 3 risks were high systolic blood pressure (211·8 million [192·7 million to 231·1 million] global DALYs), smoking (148·6 million [134·2 million to 163·1 million]), high fasting plasma glucose (143·1 million [125·1 million to 163·5 million]), high BMI (120·1 million [83·8 million to 158·4 million]), childhood undernutrition (113·3 million [103·9 million to 123·4 million]), ambient particulate matter (103·1 million [90·8 million to 115·1 million]), high total cholesterol (88·7 million [74·6 million to 105·7 million]), household air pollution (85·6 million [66·7 million to 106·1 million]), alcohol use (85·0 million [77·2 million to 93·0 million]), and diets high in sodium (83·0 million [49·3 million to 127·5 million]). From 1990 to 2015, attributable DALYs declined for micronutrient deficiencies, childhood undernutrition, unsafe sanitation and water, and household air pollution; reductions in risk-deleted DALY rates rather than reductions in exposure drove these declines. Rising exposure contributed to notable increases in attributable DALYs from high BMI, high fasting plasma glucose, occupational carcinogens, and drug use. Environmental risks and childhood undernutrition declined steadily with SDI; low physical activity, high BMI, and high fasting plasma glucose increased with SDI. In 119 countries, metabolic risks, such as high BMI and fasting plasma glucose, contributed the most attributable DALYs in 2015. Regionally, smoking still ranked among the leading five risk factors for attributable DALYs in 109 countries; childhood underweight and unsafe sex remained primary drivers of early death and disability in much of sub-Saharan Africa.
INTERPRETATION: Declines in some key environmental risks have contributed to declines in critical infectious diseases. Some risks appear to be invariant to SDI. Increasing risks, including high BMI, high fasting plasma glucose, drug use, and some occupational exposures, contribute to rising burden from some conditions, but also provide opportunities for intervention. Some highly preventable risks, such as smoking, remain major causes of attributable DALYs, even as exposure is declining. Public policy makers need to pay attention to the risks that are increasingly major contributors to global burden. FUNDING: Bill & Melinda Gates Foundation.
Copyright © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27733284      PMCID: PMC5388856          DOI: 10.1016/S0140-6736(16)31679-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  105 in total

1.  Country actions to meet UN commitments on non-communicable diseases: a stepwise approach.

Authors:  Ruth Bonita; Roger Magnusson; Pascal Bovet; Dong Zhao; Deborah C Malta; Robert Geneau; Il Suh; Kavumpurathu Raman Thankappan; Martin McKee; James Hospedales; Maximilian de Courten; Simon Capewell; Robert Beaglehole
Journal:  Lancet       Date:  2013-02-12       Impact factor: 79.321

2.  2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Monica M Colvin; Mark H Drazner; Gerasimos Filippatos; Gregg C Fonarow; Michael M Givertz; Steven M Hollenberg; JoAnn Lindenfeld; Frederick A Masoudi; Patrick E McBride; Pamela N Peterson; Lynne Warner Stevenson; Cheryl Westlake
Journal:  Circulation       Date:  2016-05-20       Impact factor: 29.690

3.  Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010.

Authors:  Gonghuan Yang; Yu Wang; Yixin Zeng; George F Gao; Xiaofeng Liang; Maigeng Zhou; Xia Wan; Shicheng Yu; Yuhong Jiang; Mohsen Naghavi; Theo Vos; Haidong Wang; Alan D Lopez; Christopher J L Murray
Journal:  Lancet       Date:  2013-06-08       Impact factor: 79.321

Review 4.  Recent advances in the management of coronary artery disease: highlights from the literature.

Authors:  John G T Augoustides; Harish Ramakrishna
Journal:  J Cardiothorac Vasc Anesth       Date:  2009-04       Impact factor: 2.628

5.  Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.

Authors:  Salim Yusuf; Eva Lonn; Prem Pais; Jackie Bosch; Patricio López-Jaramillo; Jun Zhu; Denis Xavier; Alvaro Avezum; Lawrence A Leiter; Leopoldo S Piegas; Alexander Parkhomenko; Matyas Keltai; Katalin Keltai; Karen Sliwa; Irina Chazova; Ron J G Peters; Claes Held; Khalid Yusoff; Basil S Lewis; Petr Jansky; Kamlesh Khunti; William D Toff; Christopher M Reid; John Varigos; Jose L Accini; Robert McKelvie; Janice Pogue; Hyejung Jung; Lisheng Liu; Rafael Diaz; Antonio Dans; Gilles Dagenais
Journal:  N Engl J Med       Date:  2016-04-02       Impact factor: 91.245

6.  National Particle Component Toxicity (NPACT) Initiative: integrated epidemiologic and toxicologic studies of the health effects of particulate matter components.

Authors:  Morton Lippmann; Lung-Chi Chen; Terry Gordon; Kazuhiko Ito; George D Thurston
Journal:  Res Rep Health Eff Inst       Date:  2013-10

Review 7.  Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies.

Authors:  Andrew Mente; Martin O'Donnell; Sumathy Rangarajan; Gilles Dagenais; Scott Lear; Matthew McQueen; Rafael Diaz; Alvaro Avezum; Patricio Lopez-Jaramillo; Fernando Lanas; Wei Li; Yin Lu; Sun Yi; Lei Rensheng; Romaina Iqbal; Prem Mony; Rita Yusuf; Khalid Yusoff; Andrzej Szuba; Aytekin Oguz; Annika Rosengren; Ahmad Bahonar; Afzalhussein Yusufali; Aletta Elisabeth Schutte; Jephat Chifamba; Johannes F E Mann; Sonia S Anand; Koon Teo; S Yusuf
Journal:  Lancet       Date:  2016-05-20       Impact factor: 79.321

8.  Trends in AIDS Deaths, New Infections and ART Coverage in the Top 30 Countries with the Highest AIDS Mortality Burden; 1990-2013.

Authors:  Reuben Granich; Somya Gupta; Bradley Hersh; Brian Williams; Julio Montaner; Benjamin Young; José M Zuniga
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

9.  Mendelian randomisation and causal inference in observational epidemiology.

Authors:  Nuala A Sheehan; Vanessa Didelez; Paul R Burton; Martin D Tobin
Journal:  PLoS Med       Date:  2008-08-26       Impact factor: 11.069

Review 10.  The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews.

Authors:  Amy O'Donnell; Peter Anderson; Dorothy Newbury-Birch; Bernd Schulte; Christiane Schmidt; Jens Reimer; Eileen Kaner
Journal:  Alcohol Alcohol       Date:  2013-11-13       Impact factor: 2.826

View more
  1094 in total

1.  Bio3Air, an integrative system for monitoring individual-level air pollutant exposure with high time and spatial resolution.

Authors:  Haoxiang Cheng; Liping Wang; Dongbin Wang; Jushan Zhang; Long Cheng; Pengfei Yao; Zhongyang Zhang; Antonio Di Narzo; Yuan Shen; Jing Yu; Changhui Wang; Lihong Fan; Jianwei Lu; Jingkun Jiang; Ke Hao
Journal:  Ecotoxicol Environ Saf       Date:  2018-11-28       Impact factor: 6.291

Review 2.  Inflammatory cytokines regulate renal sodium transporters: how, where, and why?

Authors:  Allison E Norlander; Meena S Madhur
Journal:  Am J Physiol Renal Physiol       Date:  2017-04-12

Review 3.  Treatment failure in inflammatory arthritis: time to think about syndemics?

Authors:  Elena Nikiphorou; Heidi Lempp; Brandon A Kohrt
Journal:  Rheumatology (Oxford)       Date:  2019-09-01       Impact factor: 7.580

Review 4.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

5.  Limiting Alcohol Outlet Density to Prevent Alcohol Use and Violence: Estimating Policy Interventions Through Agent-Based Modeling.

Authors:  Alvaro Castillo-Carniglia; Veronica A Pear; Melissa Tracy; Katherine M Keyes; Magdalena Cerdá
Journal:  Am J Epidemiol       Date:  2019-04-01       Impact factor: 4.897

Review 6.  The legal determinants of health: harnessing the power of law for global health and sustainable development.

Authors:  Lawrence O Gostin; John T Monahan; Jenny Kaldor; Mary DeBartolo; Eric A Friedman; Katie Gottschalk; Susan C Kim; Ala Alwan; Agnes Binagwaho; Gian Luca Burci; Luisa Cabal; Katherine DeLand; Timothy Grant Evans; Eric Goosby; Sara Hossain; Howard Koh; Gorik Ooms; Mirta Roses Periago; Rodrigo Uprimny; Alicia Ely Yamin
Journal:  Lancet       Date:  2019-04-30       Impact factor: 79.321

7.  Pharmacological inhibition of Receptor Protein Tyrosine Phosphatase β/ζ (PTPRZ1) modulates behavioral responses to ethanol.

Authors:  Rosalía Fernández-Calle; Marta Vicente-Rodríguez; Miryam Pastor; Esther Gramage; Bruno Di Geronimo; José María Zapico; Claire Coderch; Carmen Pérez-García; Amy W Lasek; Beatriz de Pascual-Teresa; Ana Ramos; Gonzalo Herradón
Journal:  Neuropharmacology       Date:  2018-05-09       Impact factor: 5.250

8.  The Burden of Cardiovascular Disease in Sub-Saharan Africa and the Black Diaspora.

Authors:  Richard F Gillum
Journal:  J Racial Ethn Health Disparities       Date:  2018-03-19

Review 9.  Genes that make you fat, but keep you healthy.

Authors:  R J F Loos; T O Kilpeläinen
Journal:  J Intern Med       Date:  2018-10-02       Impact factor: 8.989

10.  Ten-year incidence of hypertension in a Swiss population-based sample Incidence of hypertension in Switzerland.

Authors:  Ana Sofia Quinteiros Fidalgo; Peter Vollenweider; Pedro Marques-Vidal
Journal:  J Hum Hypertens       Date:  2018-10-03       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.